医学
危险分层
心脏病学
内科学
肺动脉高压
分层(种子)
休眠
植物
生物
种子休眠
发芽
作者
Nicola Benjamin,Veronika Schiffer,Carolin Resag,Panagiota Xanthouli,Moritz Braun,Satenik Harutyunova,Christina A. Eichstaedt,Benjamin Egenlauf,Alberto M. Marra,Eduardo Bossone,Antonio Cittadini,David G. Kiely,Ekkehard Grünig
标识
DOI:10.1016/j.echo.2024.11.015
摘要
BACKGROUND: In healthy subjects, sex differences in right heart function have been detected for various echocardiographic parameters. The objective of this study was to investigate sex differences in echocardiographic European Society of Cardiology (ESC)/European Respiratory Society (ERS) risk stratification parameters and their impact on survival estimation in patients with pulmonary arterial hypertension (PAH). METHODS: In this retrospective, cross-sectional study with a mean follow-up time of 3.2 ± 2.65 years (median, 2.78 years), clinical parameters including right atrial (RA) area, right ventricular area, and tricuspid annular plane systolic excursion (TAPSE) divided by systolic pulmonary artery pressure (sPAP) were assessed. Thresholds of ESC/ERS risk stratification were compared using multivariable Cox regression analysis. RESULTS: , P < .001). This difference was consistent throughout all World Health Organization functional classes and cardiac index risk groups, except for the RA area in the cardiac index high-risk group and World Health Organization functional class IV. On multivariable analysis, indexed values showed more pronounced differences for age-adjusted survival analysis compared with ESC/ERS risk stratification thresholds. TAPSE/sPAP showed no significant sex differences, which makes this parameter a robust prognostic predictor. CONCLUSIONS: This is the first study focusing on sex differences in right heart size obtained by echocardiography in patients with PAH. For risk stratification indexing RA area to body surface area could be more reflective of body composition. In contrast, TAPSE/sPAP values were not sex dependent and were a robust prognostic factor in patients with PAH.
科研通智能强力驱动
Strongly Powered by AbleSci AI